
Oaktree Specialty (OCSL) | Stock Overview & Key Data
Oaktree Specialty Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $30.60 on July 7, 2014
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Oaktree Specialty OCSL | 1.14B Small-cap | -0.92% | -6.77% | -8.03% | -13.91% | -15.48% | -21.00% | -29.75% | -12.15% |
BlackRock BLK | 179.74B Large-cap | 0.37% | 5.57% | 7.26% | 30.76% | 14.08% | 22.28% | 110.88% | 89.79% |
Brookfield BN | 103.45B Large-cap | 0.42% | 5.16% | 6.86% | 36.46% | 19.39% | 29.40% | 110.25% | 141.60% |
WisdomTree WT | 2.00B Small-cap | -2.16% | 0.67% | 8.97% | 59.44% | 34.52% | 37.51% | 184.52% | 242.57% |
SRH Total Return STEW | 1.76B Small-cap | -0.82% | -1.79% | 1.46% | 8.32% | 13.55% | 15.21% | 63.36% | 77.97% |
Acadian Asset AAMI | 1.75B Small-cap | -5.52% | -7.87% | 23.04% | 90.68% | 79.29% | 95.19% | 173.77% | 210.34% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is OCSL's 52-week high and low?
- In the last 52 weeks, Oaktree Specialty reached a high of $16.66 (on October 21, 2024) and a low of $12.50 (on April 9, 2025).
- What is the market cap and P/E ratio for OCSL?
- Curious about Oaktree Specialty's size and valuation? Its market capitalization stands at 1.14B. When it comes to valuation, the P/E ratio (trailing twelve months) is 22.75, and the forward P/E (looking ahead) is 5.84.
- Does OCSL pay dividends? If so, what's the yield?
- Yes, Oaktree Specialty is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 17.76%, and the company has paid an average of $2.41 per share annually over the past 3 years.
- Who are Oaktree Specialty's main competitors or similar companies to consider before investing?
When looking at Oaktree Specialty, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return BlackRock
BLK179.74B Financial Services Asset Management 22.28% 110.88% Brookfield
BN103.45B Financial Services Asset Management 29.40% 110.25% WisdomTree
WT2.00B Financial Services Asset Management 37.51% 184.52% SRH Total Return
STEW1.76B Financial Services Asset Management 15.21% 63.36% Acadian Asset
AAMI1.75B Financial Services Asset Management 95.19% 173.77% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Oaktree Specialty Lending Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Oaktree Specialty's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.11%, the Debt to Equity ratio from the most recent quarter is 99.18, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for OCSL?
- Looking at Oaktree Specialty's growth, its revenue over the trailing twelve months (TTM) was $334M. Compared to the same quarter last year (YoY), quarterly revenue grew by -20.80%, and quarterly earnings saw a YoY growth of 3,324.30%.
- How much of OCSL stock is held by insiders and institutions?
- Wondering who owns Oaktree Specialty stock? Company insiders (like executives and directors) hold about 0.31% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 40.12%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.